Neonatal soft tissue sarcomas: The influence of pathology on treatment and survival

Peter W. Dillon, Thomas V. Whalen, Richard G. Azizkhan, Gerald M. Haase, Arnold G. Coran, Denis R. King, Mark Smith

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


Introduction: A multi-institutional study was conducted by the Children's Cancer Group (CCG) to evaluate all soft tissue sarcomas diagnosed within the first month of life. Methods: A retrospective study by 11 CCG institutions of patient records from 1971 to 1991 were reviewed for demographic data, pathology, therapy, and outcome. Results: 32 neonates with soft tissue sarcomas were identified. There were 21 boys and 11 girls. Pathology was equally divided into three groups: Congenital fibrosarcoma (CFS) (12), rhabdomyosarcoma (RMS) (11), and non-RMS soft tissue sarcomas (NRSTS) (9). Anatomic sites consisted of head/neck (11), extremity (9), trunk (8), pelvis (3), and unknown (2). Overall survival rate was 59% ( 19 32). Conclusion: Soft tissue sarcomas in the neonate comprise three general groups with survival rates dependent on pathology and extent of disease.

Original languageEnglish (US)
Pages (from-to)1038-1041
Number of pages4
JournalJournal of pediatric surgery
Issue number7
StatePublished - Jul 1995

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Neonatal soft tissue sarcomas: The influence of pathology on treatment and survival'. Together they form a unique fingerprint.

Cite this